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 Haemonchus contortus is a parasitic nematode known to infect ruminant animals such as 
sheep, goats and cattle. Despite several different anthelmintic drugs available to control the 
spread of this infection, H. contortus has shown resistance to all of them. In order to combat the 
infection, a novel drug target must be found and characterized. Hco-UNC-49 is unique parasitic 
nematode γ-aminobutyric acid (GABA) gated chloride channel that may prove to be a novel drug 
target. The objective of this thesis was to characterize intramolecular interactions of Hco-UNC-
49B. Two sets of oppositely charged residues were chosen based on their proximity to each other 
in a model of Hco-UNC-49 generated using the C. elegans GluCl crystal structure as a template. 
These residues are predicted to form salt bridges in Hco-UNC-49B which may contribute to 
structure, function, and molecular interactions with ligands. Each amino acid was mutated to an 
alanine, followed by a mutation to a similar charged amino acid, and finally a swap between the 
two residues encompassing the salt bridge. It was found that all residues chosen were critical for 
receptor function to varying degrees. R159 may be interacting with D83 by either a hydrogen or 
ionic interaction. Overall, this thesis revealed a probable salt bridge that may be conserved 
among GABA receptors, as well as one novel interaction that may be unique to Hco-UNC-49. 
These results expose similarities and differences between Hco-UNC-49 and mammalian GABA 
receptors that may be vital for the creation of new anthelmintics. 
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1. Introduction and significance  
 The infections caused by parasitic nematodes is a significant economic burden to the 
wool, milk and food industry. Haemonchus contortus is a parasitic nematode that infects sheep 
and other ruminant animals by feeding on their blood while in the host’s abomasum (Schwarz et 
al., 2013). There are many anthelmintic drugs that have be used to combat this infective parasite. 
However, overuse and reliance on these drugs have resulted in increased resistance (O’Connor et 
al., 2006). Therefore, in order to counter infections caused by H. contortus, new anthelmintics 
must be found. One target for such treatment is the nematode GABA receptor, which differs 
from the GABA receptors found in the mammalian host (Schuske et al., 2004). The H. contortus’ 
GABA receptor, Hco-UNC-49, is composed of five subunits each with four transmembrane 
domains including a cys-loop and, when bound together, form a pentameric chloride channel 
(Connolly et al., 2004). The subunit dimers are composed of loops A to C on the principle 
subunit, and loops D to F on the complimentary subunit. Together, these loops form the agonist 
binding site. The wildtype channel requires both Hco-UNC49-B and C subunits forming a 
heterodimeric channel. Using many techniques such as sequence homology, modelling and 
electrophysiology, the nematode GABA receptor can be characterized and further understood 
both in sequence and function. Many studies have already determined specific residues important 
in GABA binding; however, further characterization of the intramolecular interactions, such as 
salt bridges, is still required.  
Salt bridges are composed of two oppositely charged amino acid residues which are close 
enough (within 4.0Å) to experience electrostatic attraction (Bosshard et al., 2004) and in which 
one pair of heavy atoms is within hydrogen bonding distance (Donald et al., 2011).  These salt 
bridges can contribute to protein structure, the specificity of interactions with the proteins, and 
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interactions with other biomolecules (Bosshard et al., 2004). The net electrostatic free energy of 
a salt bridge can be separated into three components: charge-charge interactions, interactions of 
charges with permanent dipoles and desolvation of charges (Bosshard et al., 2004). 
The aim of this thesis research was to help in further characterization and understanding of 
Hco-UNC-49 which will aid in the production of novel drug candidates to target H. contortus’ 
GABA receptors and provide a treatment option for infected animals.   
2. Objectives of the Thesis 
  The main objective of the thesis was to examine intramolecular interactions between 
residues of the Hco-UNC-49 receptor using in silico modeling and site-directed mutagenesis. 
The mutations were chosen by determining the distances between two residues using a homology 
model of Hco-UNC-49. Only charged residues were included for analysis. These mutations 
included mutations of each residue to an alanine, then a mutation to a residue with a charge 
similar to the wild type residue, and finally a swap mutation was utilized to attempt to rescue the 
receptor’s function. This approach determines potential intramolecular interactions between 
residues possibly involved in the unique structure and function of Hco-UNC-49.  
3. Literature Review 
3.1 Haemonchus contortus background 
 Haemonchus contortus is a nematode parasite that spends its parasitic life stages in the 
abomasum of ruminants such as sheep and goats. H. contortus, otherwise known as the barber’s 
pole worm, is a strongylid nematode which is transmitted orally from one host’s excrement to 
another (Schwarz et al., 2013).The parasite attaches to the wall of the abomasum and feeds on 
the blood of the animal. This infection is known as haemonchosis and causes many different 
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health complications including anemia, hypoproteinemia, edema, and weakness; the infection 
may even result in death (Manninen et al., 2008).  
 
3.2 Distribution of H. contortus and economic concerns 
 This infection presents many health concerns for the infected hosts and can contribute to 
economic and industrial losses worldwide. These include reduction of quantity and quality of 
wool, decreased milk production, and decreased reproduction resulting in decreased meat and 
herd sizes (Qamar et al, 2011).  
Typically, H. contortus is seen in tropical and subtropical areas; however, as of 2008, H. 
contortus was found in the northern regions of Finland. While it has been found in Finland since 
1933, it has not been found this far north in Finland until recently. In Sweden, H. contortus was 
detected near the Arctic Circle. Due to the arrested development of the fourth larval stage, the 
parasite is able to survive the winter while within a host (Manninen et al., 2008). While the 
infection is generally confined to ruminants, there are cases in which H. contortus has infected 
humans (Roberts, 2000; Pestechian et al., 2014). 
Over-use and reliance on anthelmintic drugs across the world has resulted in resistance to 
many treatments. Consequently, haemonchosis has a severe economic impact.  In 2011, Qamar 
et al. showed that parasitic nematodes cost Australia up to $369 million annually. As well, H. 
contortus was shown to cost $26m, $46m, and $103m for Kenya, South Africa and India 





3.3 Life stages 
 In 1915, Veglia described in full detail the growth and development of H. contortus. The 
parasitic nematode has five stages in its life cycle. Each stage can be divided into two substages, 
one of activity, and one of lethargy, in which they undergo structural changes. The first two 
stages, as well as half of the third stage, are free living. Part of the third stage, through to the fifth 
stage occur within the host as a parasite. H. contortus begins its life cycle as an egg laid in the 
abomasum of a ruminant animal (Figure 1). These eggs require oxygen and are excreted by the 
host. The eggs hatch outside of the host in the feces and develop into the first-stage larvae (L1). 
The L1 larvae continues to develop through two molts to the L2 larvae and eventually the L3 
larvae, where they are capable of climbing blades of grass using water droplets. The L3 larvae 
are ingested by the new host where they becomes unsheathed and develop into an L4 larvae 
(Roeber et al., 2013). The L4 larvae are able to enter a state of hypobiosis, an arrested stage of 
development (Veglia, 1915).  This is dependent on many factors including seasonal, host-
immunity and parasitic factors (Veglia, 1915). The L4 larvae will then develop into the mature 
adult worms. The adult female is capable of laying 4500 eggs daily and can grow up to 30 mm 
long, whereas the male adult worm can only grow up to 18 mm long (Coyne and Smith., 1992; 




Figure 1. Image portraying the life cycle of Haemonchus contortus. L1 through L3 are the free living nematode. *L3 
represents transition from free-living to parasitic life stages in which the nematode becomes unsheathed. L4 and the 
adult worm are parasitic. Eggs are laid in the host but are excreted by the host to develop into L1 free- living 
nematodes. Created by Josh Foster as a summary from Veglia, 1915. 
 
 Temperature and moisture are key factors which influence the development of H. 
contortus. The eggs and initial larval stages are very susceptible to lower temperatures and lack 
of moisture. H. contortus generally survives in areas with summer-dominant temperatures and 
rainfall. This includes large areas of Asia, India, Africa, Australia, China and America. These 
areas tend to have warmer temperatures and moisture. However, there has been an increase of 
incidences of infection in more northern countries such as Sweden, France, Denmark and the 
Netherlands. This is thought to be due to the hypobiosis of the L4 larvae (O’Connor et al., 2006). 
It has been noted that the L3 larvae is capable of surviving up to 6 months with optimal 
temperature and moisture, while the adult worm can only survive several months inside of its 
host (Veglia, 1915), but long enough to survive cold winters (Qamar et al, 2011). 
3.4 Control of H. contortus. 
 One of the most prominent methods of treating haemonchosis is the use of anthelmintic 
drugs. However, the over-use and unnecessary treatments with these drugs has caused an 
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increase in resistance in parasitic nematodes (O’Connor et al., 2006).  As of 2009, H. contortus 
was known to be resistant to all known anthelmintics with only one exception, amino-acetonitril 
derivatives (AAD’s) (Kaminksy et al., 2008). This resistance and over reliance on anthelmintics 
has resulted in the need to find alternatives to manage the infections without the use of these 
chemotherapeutics (O’Connor et al., 2006).  
 Integrated parasite management (IPM) focuses on using specific environmental 
conditions to control the spread of infection (O’Connor et al., 2006). IPM generally targets the 
free living life stages rather than the parasitic stages (O’Connor et al., 2006).  This involves 
intensive rotational grazing and higher stocking rates to reduce close grazing and consumption of 
parasites. The use of rotational grazing systems is very effective to reduce the amount of time 
that the ruminant animals spend on specific fields which will decrease the chance of infection 
and allow for more environmental control over the fields (O’Connor et al., 2006). This way, the 
immediate environmental conditions can be used to reduce the chance of infection (O’Connor et 
al., 2006).      
4. Anthelmintic Drugs 
Anthelmintic drugs are used to treat animals with parasitic worm infections. These 
worms (including trematodes, cestodes and nematodes) may infect humans, livestock and 
domesticated pets. Anthelmintic drugs have been over-used, resulting in high resistance in many 
parasitic worms (Roeber et al., 2013). Despite the fact that IPM methods are becoming more 
necessary for controlling the spread of H. contortus, a treatment option for infected animals is 
still necessary. There is little motivation for development of new anthelmintics because most 
nations that require the drugs do not have the money to invest in drug discovery (Holden-Dye et 
al., 2005). The drug ivermectin has been quite successful over the past 30 years and resulted in a 
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decreased pressure for alternative anthelmintics until recently (Holden-Dye et al, 2005). There 
are only a small number of different classes of anthelmintics which are separated by their 
chemical characteristics (examples in Figure 2), many of which act on ligand gated ion channels. 
There are three major classes used in veterinary medicines. These are summarized below. 
4.1 Benzimidazoles 
 Benzimidazoles are broad spectrum anthelmintics which act on β-tubulin and prevent the 
formation of microtubules (Lacey, 1990). Tubulin is required for organelles involved in motility, 
division and secretion as well as glucose uptake and emptying of glycogen reserves (Lacey, 
1990). Benzimidazoles also affects egg production.  Examples include thiabendazoles, 
mebendazole, and fenbendazole . 
4.2 Imidazthiazoles  
These anthelmintic drugs act as an agonist for the nicotinic acetylcholine receptors 
(nACh) in nematodes (Holden-dye, et al., 2014). This causes spastic muscle paralysis due to over 
activation of the receptors (Holden-dye, et al., 2014). They also indirectly target 
acetylcholinesterase inhibitors (Harder et al., 2003). An example of an imidazthiazole is the drug 
Levamisole. 
4.3 Macrocyclic lactones 
 Macrocyclic lactones are composed of two different subclasses of anthelmintics which 
are both thought to act on glutamate-gated chloride channels (GluCls), as well as GABA 
channels (Forrester et al., 2002; Crump et al. 2011). These subclasses include avermectins and 
milbemycins. Examples include ivermectin, used in livestock, as well as moxidectin which is 
used in livestock as well as cats and dogs (Harder et al., 2003). Ivermectin is a very potent drug 
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which causes paralysis of the nematode pharyngeal and body wall musculature (Holden-dye, et 
al., 2014). 
4.4 Other classes of Anthelmintic drugs 
There are other smaller classes of anthelmintics. These include examples such as 
piperazine, which acts on GABA receptors; spiroindoles which cause paralysis by acting as an 
antagonist for acetylcholine receptors; cyclooctadepsipeptides which are thought to act on 
calcium and potassium-dependent mechanisms; flavonoids which are found to be associated with 
DAF-16 activation; spiroindolines which act on the vesicular acetylcholine transporter, UNC-17; 
aminophenylamidines which act on AChR; Cry proteins from Bacillus thuringiensis which are 
pore forming proteins;  nitazoxanide which acts as a pyruvate ferredoxin oxioreductase inhibitor; 
and fluoroalkenyls which have a broad range of effects. There are also amino-acetonitril 
derivatives (ADD’s) which act as broad spectrum anthelmintics (Holden-dye et al., 2014). It is 
thought that ADD’s act on nematode specific acetylcholine receptor subunits (Kaminsky et al., 
2008). 
  
Figure 2. Examples of different anthelmintic drugs. Created by Josh Foster. 
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 Due to the developing resistance to anthelmintic drugs in H. contortus, a novel drug 
candidate must be discovered to manage the spread of haemonchosis, as well as treatment 
options for other infected animals. Certain ligand-gated ion channels (LGICs) may be potential 
targets for new anthelmintic drug candidates.  
5. Ligand-Gated Ion Channels 
Ligand-gated Ion Channels (LGIC) play key roles in the nervous system.  The binding of specific 
neurotransmitters at synapses in the nervous system causes activation of these receptors 
triggering a reaction in the postsynaptic membrane allowing for anions or cations to enter into 
the postsynaptic cell (Nys et al., 2013). The binding of the neurotransmitter ligand causes a 
conformational change which opens the channel and allows ions to flow through due to their 
electrochemical gradients. This only occurs for a short duration of time (milliseconds), but the 
flow of ions is great enough to cause a rapid response (Unwin, 1993). Many of these LGICs are 
composed of five subunits located in the cell membrane forming a channel.  Many LGICs are 
heteromultimers with many genes encoding the different subunits. This allows for a large 
diversity between receptors giving many different characteristics such as pharmacological and 
biophysical properties, expression patterns within tissue and between different kinds of tissue 
(Alexander et al., 2011).  
  Cysteine-loop LGICs (cys-loop LGIC) are pentameric neurotransmitter receptor channels 
that function in the central and peripheral nervous system. These channels have been found 
throughout vertebrates, invertebrates and prokaryotes, and have homologous structures and 
similar mechanisms of action (Thompson et al, 2010). These receptors are the targets of many 
pharmaceutical drugs as well as pesticides. Each subunit of the cys-loop LGIC is composed of an 
extracellular N-terminus with a ligand binding site as well as a 13-amino acid loop which 
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contains two cysteine residues forming a disulfide bond (Connolly et al., 2004; Thompson et al, 
2010). The pentameric channel can be composed of a variety of subunits arranged pseudo-
symmetrically around a central pore (Thompson et al, 2010) (Figure 3). This pore allows for 
anions or cations to flow with their electrochemical gradient either into or out of the cell. The 
extracellular domains (ECD) of the cys-loop LGIC have been difficult to model and so, until 
recently, the acetylcholine binding protein was used as a model due to its homology to cys-loop 
receptors (Thompson et al, 2010). The ligand binding site occurs between two adjacent subunits 
and is found between 3 loops (A, B and C) of the principal subunit, and three β-sheet ‘loops’ (D, 
E and F) of the complimentary subunit (Thompson et al, 2010). These loops contain aromatic 
residues which form cation-π interactions with the natural ligand. There are four transmembrane 
domains (TMD), M1 through M4, in each subunit of the cys-loop receptor (Figure 3.) The M2 
regions of each subunit line the central pore and are responsible for the selectivity of the ions 
flowing through the channel (Thompson et al, 2010;Connolly et al., 2004) while the M1, M3 and 
M4 shield the channel from the lipid surroundings. M2 has specific functions in channel gating 
and opening, and bridges the ECD and the TMD, which involves a transmission of energy from 
ligand binding into channel opening (Thompson et al, 2010). The movement of the ECD as well 
as the M2-M3 linker on the extracellular side destabilizes a hydrophobic region moving it away 
from the central pore and allowing for the channel to open. While some receptors show salt-
bridges connecting the ECD and TMD, it is postulated that others maintain a global electrostatic 
attraction instead (Thompson et al., 2010). It has been shown that M1, M2 and M3 maintain 
position within the membrane while M4 is less restrained (Thompson et al, 2010). M3 and M4 
have an intracellular loop which can be described as a ‘hanging-basket’ type structure which 
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characterizes the intercellular domain (ICD) and is involved in the positioning of the channel 
within the membrane (Thompson et al, 2010).   
The structural and functional homology of cys-loop receptors allows for comparison of 
channels amongst many different species, from vertebrates to invertebrates. In vertebrates, 
excitatory channels are cationic and include both serotonin-gated channels and acetylcholine-
gated channels. Inhibitory channels are anionic and include both GABAA and glycine-gated 
channels. Invertebrates have far more numerous LGIC which include channels activated by 
histamine, glutamate, acetylcholine, serotonin, dopamine, and tyramine. Interestingly, excitatory 
GABA receptors have been identified in invertebrates (Schuske et al., 2004). 
 
Figure 3. Representation of the pentameric channel with ion flow direction (top).  
The individual subunit can be seen represented with the 4 transmembrane domains 1 through 4. The orange line 
represents the disulfide bond of the cys-loop (bottom). Created by Josh Foster 
    
5.1 GABA receptors 
In vertebrates neurotransmission can result in both excitatory and inhibitory functions. This 
is dependent on a balance between excitatory and inhibitory neurotransmitters. If there is an 
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overabundance in excitatory neurotransmission it will result in epileptic seizures, whereas an 
overabundance of inhibitory neurotransmission will result in loss of consciousness (Schuske et 
al., 2004). The primary inhibitory neurotransmitter in vertebrates is GABA (Figure 4) 
(Alexander et al, 2011).   The inhibition caused by GABA occurs when the neurotransmitter 
binds to a 
 
Figure 4. Chemical structure of Gamma-Aminobutyric acid (GABA). Created by Josh Foster 
variety of different membrane-bound GABA receptors (Alexander et al., 2011). These include 
both metabotropic receptors that are G-protein coupled receptors (GABAB), as well as ionotropic 
ligand-gated ion channels (GABAA and GABAC). GABAA and GABAC are both GABA-gated 
chloride channels which, when opened, allow for the influx of chloride ions into neurons, 
inhibiting neuronal firing (Alexander et al., 2011).   
Mammalian GABAA receptors are composed of five subunits which assemble to form a 
pentameric channel. These subunits are encoded by 19 different genes. However, most 
physiological heteromers are theorized to include two α subunits, two β subunits, and one γ 
subunit. It is also found that the β3 subunit is capable of forming functional homomeric channels 
(Miller et al, 2014; Saras et al, 2008). The GABA molecule acts as a neurotransmitter and binds 
to the extracellular domain at the α/β subunit interface causing a conformational change which 
causes the transmembrane region to open the ion channel (Sigel et al., 2012). Recently, Miller et 
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al (2014) crystalized the β3 homopentamer channel (Figure 5), which shed light on the structural 
information that was previously unavailable.  It was found that the GABAAR-β3 subunits form 
the most energetically favorable interactions between ECDs by utilizing patches of hydrogen 
bonds, salt bridges and van der Waals forces. 
 
 
Figure 5. Left: Side view of the crystal structure of human GABAA-Β3 channel.  
Right: Top-down view of the GABAA-β3 channel. PDB 4COF (Miller et al., 2014) 
 
Activation of the GABAA receptor requires key molecular components of adjacent subunits 
in the extracellular loops which comprise the binding site for GABA (Accardi et al., 2011). The 
aromatic box of loops A to D directly bind to GABA (Accardi et al., 2011) or stabilize the 
binding pocket (Accardi et al., 2011). These residues include β2Y97 of loop A, β2Y157 of loop 
B, β2Y205 of loop C and α1F64 of loop D (Accardi et al., 2011).  
5.2 GABA receptors in nematodes 
While GABA is only inhibitory in vertebrate organisms, it can also be excitatory in 
invertebrates (Schuske et al., 2004; Accardi et al, 2012). In nematodes, GABA is used both as an 
inhibitory neurotransmitter, allowing for locomotion by relaxing muscles on one side of the body 
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while contraction occurs on the other, as well as an excitatory neurotransmitter in expulsion of 
intestinal contents (Schuske et al., 2004). In nematodes the primary inhibitory GABA receptor is 
UNC-49. Caenorhabditis elegans has been found to express three UNC-49 subunits including 
Cel-UNC-49A, Cel-UNC-49B and Cel-UNC-49C (Bamber et al., 1999). These subunits are 
encoded by a single gene, unc-49, which undergoes alternative splicing and forms different 
functional channels (Bamber et al., 1999). These channels maintain similar N-terminal ligand 
binding domains, but vary in their C-terminus. While it is possible for Cel-UNC-49B to form 
homomeric channels, it appears as though the Cel-UNC-49B/C heteromeric channel is the native 
channel in C. elegans (Bamber et al., 1999). The Cel-UNC-49A subunit does not appear to be 
expressed in physiologically significant levels (Bamber et al., 1999). The heteromeric Cel-UNC-
49B/C channel plays a role in locomotion and is expressed at neuromuscular junctions (Bamber 
et al., 1999). Relative to the Cel-UNC-49B homomeric channel, the heteromeric Cel-UNC-
49B/C shows decreased sensitivity to GABA as well as altered responses to both modulators and 
inhibitors which indicates functional differences between the two subunits (Bamber et al., 2005). 
While UNC-49 receptors share a relation with vertebrate receptors, they also show 
pharmacological differences, such as the insensitivity to bicuculline, and altered responses to the 
enhancing effects of benzodiazepine (Bamber et al., 2005). Bamber et al., (1999) found that 
these subunits are not actual orthologues of the GABAA receptors found in vertebrates, but they 
do share functional and structural overlap suggesting conservation within GABA receptor 
families. 
5.3 GABA receptors in H. contortus 
The function of GABA reception in parasitic nematodes is less understood relative to C. 
elegans. There are two gene orthologues of the unc-49 subunits in H. contortus. These include 
16 
 
unc-49B and unc-49C (Siddiqui et al., 2010). There are many shared functional characteristics 
between the C. elegans and H. contortus UNC-49B and C proteins. However, the Hco-UNC-49B 
receptor (Figure 6) shows some key functional differences (Siddiqui et al., 2010). It is interesting 
to note that while the heteromeric channel in C. elegans shows decreased sensitivity to GABA, it 
is the Hco-UNC-49B homomeric channel (not the heteromeric channel) that shows decreased 
sensitivity in H. contortus (Siddiqui et al., 2010). For example, Siddiqui et al., 2010 showed that 
co-expressing the Cel-UNC-49B subunit with Hco-UNC-49C subunits demonstrates a decreased 
sensitivity to GABA which is consistent with the C. elegans heteromeric channels. When the 
expression is reversed (i.e., expressing Hco-UNC-49B and Cel-UNC-49C), there is a higher 
sensitivity to GABA which indicates that the Hco-UNC-49B subunit of H. contortus increases 
GABA sensitivity. The cause of the increased sensitivity is unknown, although differences in the 
length of the intracellular loops (M3-M4) between C. elegans and H. contortus have been 
detected. Also, the homomeric channel is more sensitive to the channel blocker picrotoxin, which 
indicates that the picrotoxin resistance can be attributed to the Hco-UNC-49C subunit of the 
heteromeric channel (Siddiqui et al., 2010) 
While the mammalian GABAA receptor may not be an actual orthologue of the UNC-49 
proteins, it has been found that N-terminus of UNC-49B shares 69% and 73% sequence 
similarity to the α1 and β2 subunits, respectively. Many residues of the discontinuous loops A 
through F are conserved, including the residues of the aromatic box which forms the binding site. 
Accardi et al., (2011) found that the specific residues of the aromatic box of the mammalian 
GABAA receptor (α1F64 of loop D, β2Y97 of loop A, β2Y157 of loop B, and β2Y205 of loop C) 
is functionally conserved in Hco-UNC-49B as Y85, F127, Y187 and Y239. Mutations of these 
residues substantially impact the function of Hco-UNC-49 channels.  
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 Although there are many similarities between C. elegans and H. contortus GABA 
receptors, as well as some functional similarities with the mammalian GABAA receptor, further 
molecular studies are needed to better understand the function of GABA neurotransmission in 
parasitic nematodes. Some amino acid residues that may play an important role in the function of 
the UNC-49 receptor of H. contortus include residues that have a charge. As stated above 
charged residues can play key roles in the formation of the structure of this channel (through salt 
bridge interactions) and its interaction with ligands.  
 
Figure 6. Model representative of the Haemonchus contortus UNC-49B homomeric channel with the 6 loops 
represented on the primary (A-C) and complimentary subunits (D-F). Created by Micah Callanan. 
Modelling of the UNC-49 receptor of H. contortus and observation of conserved regions of 
other LGIC, reveal locations which may serve as salt bridges (Figures 7 and 8). Two sets of 
residues which may be considered as potential for salt bridges in H. contortus include D83-H137 
or R159 and R241-E185. Interestingly, the crystal structure of the Human GABAA receptor 
shows similar salt bridges at these locations, and a series of bridges crossing E155-R207-E153-
K196 (Miller et al., 2014; Bergmann et al., 2013) which are equivalent to Hco-UNC-49B’s 
E185-R241-E183. In order to further understand the function of these residues a series of point 





Figure 7. Left: Residues for the proposed salt bridges shown in relation to their positions on both the primary 
(chain A) and complimentary subunits (Chain B) Right: Close up of the proposed salt bridges with distances and 
labelling of the residues. Created by Micah Callanan. 













6. Methods  
6.1. UNC-49B mutant primer design 
The amino acid sequence of Hco-UNC-49B (GenBank Accession # EU939734.1) was 
aligned with other ligand-gated chloride channels (LGCC) such as GABAc rho-1, GABAA α1, 
Cel-UNC-49B, and AChBP, (shown in Figure 8). These were used to determine conserved 
charged amino acids and were compared to a premade model of our receptor that used C. elegans 
GluCl as a template (Kaji et al., 2015) to determine distance between charged residues. If the 
residues were ~4.0Å they were considered for further examination. Fifteen mutants were 
generated using Stratagene’s web-based QuikChange® Primer Design program 
(www.stratagene.com/sdmdesigner/decault.aspx). These mutants are summarized with the pair of 
mutagenic primers in the appendices (Table 1). Each set of mutants were designed to mutate 
each half of the salt-bridge to an alanine to remove salt bridge function, then to a similarly 
charged residue to mimic function, and then to a residue swap to attempt to rescue function. 
Based on the sequence of the Human GABAA β3 receptor, D83T was created to compare Hco-
UNC-49B/C to the functional GABAA β3 homomeric mammalian channel (which naturally 




Figure 8. Sequence comparison of Hco-UNC-49B with other LGIC for the determination of charged residues.  
 
6.2. cRNA production of UNC49B mutants 
  mRNA provided by McGill university was used to produce the coding sequence of 
UNC49B and subcloned into the pT7TS vector with an untranslated X. laevis beta-globin gene 
(Figure 9). Mutations were introduced using the QuikChange II site directed mutagenesis kit and 
transformed into supercompetent cells and verified by sequencing at McGill University. cRNA 
was produced by in vitro transcription using T7 RNA polymerase and precipitated using lithium 





Figure 9. pT7Ts vector with H. contortus unc49 insertion. Created by Josh Foster 
6.3. Expression of UNC49B mutants in X. laevis oocyte 
  Xenopus laevis were anesthetized using 0.15% 3-aminobenzoic acid ethyl ester, 
methanesulphate salt buffered to pH 7 with sodium bicarbonate. Oocytes were surgically 
removed and cut into small clumps of approximately 20 eggs per clump. These were incubated in 
OR-2 (82mM NaCl, 2mM KCl, 1mM MgCl2, 5mM HEPES, pH 7.5) with type-II collagenase for 
2 hours while shaking. These were then placed in ND96 supplemented with pyruvate and 
gentamycin.  Oocytes were injected with 50 nL of either wild-type, or mutant Hco-UNC-49B 
cRNA, and wild type Hco-UNC-49C using the Drummond Nanoject microinjector. These are 
stored at 20ᵒC for one day, replacing the supplemented ND96 twice before electrophysiology. 
6.4. Two-electrode voltage clamp electrophysiology 
  Approximately forty-eight hours after injection, electrophysiology was performed using 
the Axoclamp 900A voltage clamp. Responses were recorded using varying concentrations of 
GABA dissolved in non-supplemented ND96. Microelectrodes were made using Ag|AgCl wires 
and filled with 3M KCl. Injected X. laevis oocytes were clamped and held at -60mV and left for 
1-2 minutes to stabilize before GABA was washed over the oocytes. Figure 10 illustrates the 
electrophysiology set up and theory. Data was recorded and analyzed using Clampex 10.3 
software and graphs were produced using Graphpad Prism Software 5.0. Data was collected 
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from at least four individual oocytes. To assure consistency, two different batches of oocytes 
were used. Dose-response curves are fitted to the equation: 
 
Where Imax= the maximal response, [D] is the concentration of the drug, EC50 is the 
concentration of the drug producing a half-maximal response and h is the Hill coefficient.  
 
Figure 10. Two-electrode voltage clamp electrophysiology set up with GABA and ND96 as the solution in and the 




Homomeric channel models were generated using Modeller software (Webb et al., 2014) 
with the C. elegans GluCl channel as a template. Molecular graphics and analyses were 
performed with the UCSF Chimera package. Chimera is developed by the Resource for 
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Biocomputing, Visualization, and Informatics at the University of California, San Francisco 
(supported by NIGMS P41-GM103311).  
6.6. Substituted Cysteine Accessibility Method 
Cysteine Accessibility was determined for Hco-UNC-49B R159C using the 
methanethiosulfonate (MTS) agent 2-hydroxyethylthiosulfonate (MSET) obtained from Toronto 
Research Chemicals (Toronto, ON, CA). Each oocyte was washed and subjected to their 
predetermined EC50 concentration of GABA after response stabilization by multiple hits with 
GABA. Once stabilization of responses was determined, MTSET (1mM for 1 min) was perfused 
over the oocyte followed by 5 min wash with ND96 solution. EC50 of the mutant was then 











7.1. Electrophysiology of mutants 
Amino acids were chosen based on their charge and proximity to other charged amino acids 
with the prediction that these residues would form salt bridges within the subunit of Hco-UNC-
49B. In order to assess the accuracy of this prediction, electrophysiology was performed using 
TEVC. Mutants were generated to test the participation in a potential salt bridge by first 
removing the amino acid while retaining its place by substitution with alanine. The second 
mutation tested whether the conservation of charge would rescue receptor function. In these 
mutations each residue was substituted with a residue of equal charge. Finally, swap mutations 
were generated by mutating both residues of the salt bridges to the opposite residue. Each 
mutated receptor was exposed to GABA in increasing concentrations to determine the EC50 in 
order to determine the effect each residue have on function. Upon recording, it was found that 
most receptors with mutated subunits showed some sort of activity, and clean tracings were 
established for comparisons and determination of EC50 (Table 1). While most receptors were 
functional, D83A, R159K, and all mutations at position E185 showed no responses to GABA at 







Table 1. Charged residue mutations of potential salt bridges. EC50 are compared for the heteromeric UNC-49B/C 
receptor with GABA.  
Mutation EC50 ± S.E. (μM) Number of oocytes 
Wild-Type 68.03±17.3 6 
D83A n.r. <20,000 10 
D83E 276.1 ± 36.99 5 
D83T 519.7 ± 39.72 5 
H137A 2174 ± 173.3 5 
H137K 4166 ± 744.74 5 
R159A 5469± 395.72 7 
R159K n.r. <20,000 11 
E183A 735.2 ± 131.48 6 
E185A n.r. <20,000 13 
E185D n.r. <20,000 5 
R241A 5174 ± 472.5 6 
R241K 3793 ± 435.4 6 
D83H/H137D 1315 ±140.42 5 
D83R/R159D 598.5 ± 77.09 7 
E185R/R241E n.r. < 20,000 6 
  
7.2. D83 mutations 
Based on the model created with the C. elegans’ GluCl receptor as a template, D83 was 
predicted to be in close enough proximity with both R159 as well as H137 to form a salt bridge 
(3.560Å and 3.436Å respectively). Mutations of D83 were conducted to assess its importance as 
a potential salt bridge residue. It was found that D83A showed a complete knock-out of function 
with an EC50 greater than 20mM (n=10). Conservation of the charge through D83E mutation 
showed a drastically rescued function with an EC50 of 276.1uM,  an approximately 4 fold 
decrease in sensitivity relative to the wild-type channel (n=5). Finally, to determine the 
importance of charge versus polarity, a D83T mutation was assessed and found to have an EC50 
of 519.7uM,  an approximately 8 fold decrease in sensitivity (n=5). To compare these mutations, 




Figure 11. Dose response curves of D83 mutations.  
7.3. H137 mutations 
In order to effectively determine whether the D83 residue is forming a salt bridge with 
H137, a number of mutations were analyzed. Firstly, an H137A mutation was created and was 
found to have an EC50 of 2174μM for GABA, an approximately 34 fold decrease in sensitivity 
(n=5). In order to attempt to rescue the receptor function, a similarly charged residue was 
substituted in H137K. It was found that despite the charge conservation there was an EC50 of 
4166μM, an approximately 65 fold decrease in sensitivity (n=5). This demonstrates that the 
H137K is less sensitive to GABA compared to H137A despite the conservation of charge, and in 
both cases a mutation at this position drastically hindered the receptor’s function. To compare 




Figure 12. Dose response curves of H137 mutations.  
 
7.4. R159 mutations 
The other potential half of the D83 salt bridge is R159. In order to evaluate its 
participation in this salt bridge, the same two mutations were implemented. To test the removal 
of R159, an R159A mutant was generated and analyzed through determination of the EC50 for 
GABA. It was found that R159A had an EC50 of 5469μM, an approximately 93 fold decrease in 
sensitivity (n=4). Again, to determine if conservation of charge could rescue receptor function, 
an R159K mutant was generated. However, despite conservation of charge, R159K showed no 
response to GABA at concentrations less than 20mM (n=11). To compare these mutations, dose 




Figure 13. Dose response curves of R159 mutations.  
As an additional examination of R159 an R159C mutation was examined using the 
reducing agent MTSET. It is well known that MTSET will covalently bind to cysteines which 
will affect the function of the channel. The effect can be seen using electrophysiology. Here the 





Figure 14. Results of experimentation with MTSET on R159C mutant. Blue bar is the current before 
MTSET. Grey bar is after the addition of MTSET. 
 
 
7.5. E183 mutations 
Based on the C elegans GluCl template model that was generated, E183 is in close 
proximity to K181 and potentially forms a salt bridge with this residue (2.704 Å). In order to 
determine the possible function of this residue in participation as a salt bridge, an E183A mutant 
was generated. E183A showed an EC50 of 735.2μM, an approximately 19 fold decrease in 
sensitivity relative to the wild-type EC50 (n=6). To compare this mutation with wild-type, dose 




Figure 15. Dose response curves of E183 mutations. 
7.6. E185 mutations 
E185 is in close proximity to R241 of loop C (3.384Å) allowing it to potentially form a salt 
bridge with the residue. Mutations of E185 to both alanine as well as the similarly charged 
aspartic acid yielded a complete loss of function of the channel with no responses to GABA at 
concentrations less than 20mM (Table 1).  
7.7. R241 mutations 
Finally, in order to test the potential E185/R241 salt bridge, mutants were generated for R241 
as described previously. It was found that the mutation R241A showed an EC50 of 5174μM, an 
approximately 80 fold decrease in sensitivity relative to wild-type (n=6). The R241K mutation 
showed a small increase in sensitivity to GABA with an EC50 of 3793μM, an approximately 59 
fold decrease in sensitivity relative to wildtype (n=6). Both mutations showed a drastic hindrance 
to the receptors function. To compare these mutations, dose response curves were determined 




Figure 16. Dose response curves of R1241 mutations.   
7.8. Swap mutations 
The final mutations generated to determine salt bridges are described as swap mutations. This 
utilized two mutations in each subunit to generate mutants with the two residues swapped. This 
generated the mutants D83H/H137D, D83R/R159D and finally E185R/R241E. The 
D83H/H137D mutation yielded an EC50 of 1315 ±140.4235, an approximately 39 fold decrease 
in sensitivity relative to wild type (n=5). The D83R/R159D mutant showed an EC50 of 
598±77.0919, an approximately 9 fold decrease in sensitivity relative to wild type (n=7).  The 




Figure 17. Dose response curves of charge reversal mutations.  
 
7.9. Modelling results 
A model of the binding site of Hco-UNC-49B homodimer was generated using the C. 
elegans glutamate gated chloride channel (GluCl) as a template. This model has been used for 
determining the proximity and orientation of residues for the potential salt bridges of Hco-UNC-
49B. The distances of the chosen residues (D83, H137, R159, K181, E183, E185 and R241) are 
found in Table 2 and in Figure 18.  How the model corresponds to the electrophysiology results 








Distances between residues of the predicted salt-bridges of UNC-49B.   




E185-GABA 2.961 Å 
K181-E183 2.704 Å 
 
Figure 18. Close up of the relevant residues for the proposed salt bridges with distances and labelling of 












8.  Discussion 
Many articles have addressed the importance of salt bridges in LGIC and their role in both 
ligand interactions and positioning of subunit loops (Bosshard et al., 2004).  While these articles 
address familiar organisms such as C. elegans (Siddiqui et al., 2010), D. melanogaster (Ashby et 
al., 2012), and humans (Bergmann et al., 2013), this thesis was composed to look at the unique 
GABA receptor, Hco-UNC-49. Utilizing sequence homology and a model generated using the C. 
elegans GluCl channel as a template, four potential salt bridges were chosen. In order to 
investigate these potential salt bridges and their functions, a series of mutations were generated 
and analyzed through electrophysiology.  
8.1. Salt-bridges 
Throughout this study, four potential salt bridges were investigated. These salt bridges 
included a potential bridge between D83-H137, D83-R159, E185-R241 and K181-E183.  It has 
previously been shown that there is a salt bridge critical to receptor function between the 
analogous residues of E185 and R241 in both D. melanogaster’s RDL receptor (Ashby et al., 
2012), as well as the Human GABAA receptor (Newell et al., 2004; Bergmann et al., 2013). The 
analogous residues of E185 (E155 in GABAA, E204 in RDL) and R241 (R207 in GABAA, R256 
in RDL) have both been shown to be crucial for the activation of the channel in the RDL receptor 
as well as GABAA (Ashby et al., 2012; Miller et al., 2014; Newell et al., 2004). It has been 
suggested that E155 acts as a control element involved in coupling the binding of ligands to the 
channel activation (Newell et al., 2004), and that mutations of R207 affects GABA binding and 
unbinding rates (Bergmann et al., 2013). Utilizing an agonist binding model, E155 is flanked by 
R207 and allows for an electrostatic interaction between R207 and GABA as E155 is at a correct 
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distance to form a salt bridge with GABA deep in the binding pocket (Bergmann et al., 2013). 
Finally, crystallography has revealed that the analogous residues of the GABAA receptor are in 
fact a salt bridge (Miller et al., 2014).   Interestingly, the analogous residue of E183 (i.e., E153 in 
GABAA) has been shown to form a salt bridge to a loop C residue (K196 in GABAA) which is 
not present in Hco-UNC-49B. It is also speculated that E153 is in close proximity to E155 and 
R207 and may be a part of a larger network of interacting residues (Venkatachalan et al., 2008; 
Newell et al., 2004). The crystal structure also demonstrates that a closed conformation of the 
channel is stabilized by salt bridges between E155-R207-E153 (Miller et al., 2014) which further 
supports the notion that there is a larger network of bridges present.  Our results demonstrate that 
like the GABA receptor in both Drosophila and human, the analogous residues E183, E185 and 
R241 are all important for receptor function. However, while E183 may be important it may not 
have an identical function in Hco-UNC-49 compared to its role in the human GABAA receptor. 
Literature supports the results of this thesis (Ashby et al., 2012) in that, all mutations to the 
analogous residue of E185 (in the RDL receptor) resulted in channels that were unresponsive. 
The model of Hco-UNC-49 demonstrated a distance between E185 and R241 of 3.394Å. This is 
close enough to form a salt bridge. Furthermore, in the model, the distance between E185 and the 
protonated amine of GABA is 2.961Å. This explains why mutations of E185 results in 
unresponsive channels, as E185 is crucial for the binding of GABA and allows for the 
electrostatic interaction from GABA to R241 of loop C.  Mutations of R241 also showed 
drastically impaired function of the channel, with R241A showing an approximately 80 fold 
decrease in sensitivity and R241K showing an approximately 59 fold decrease in sensitivity.  
Despite the positioning of E185 relative to GABA and R241, it was previously discussed that 
there may be a network of salt bridges from E185-R241-E183 (Miller et al., 2014). The 
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guanidinium cap of arginine allows for interactions with both E185 as well as E183, whereas the 
lysyl side chain of lysine can only permit one interaction. Consistent with this, the R241K 
mutation showed a 59 % decrease in GABA sensitivity clearly demonstrating that the preferred 
residue is an arginine. It is possible that based on the chemistry and large side chain of lysine the 
salt bridge between E183 and R241K would be broken. This is supported by the results of the 
experimentation examining the RDL receptor which demonstrated no response to GABA when 
the R241 analogous residue was mutated to alanine or lysine (Ashby et al., 2012). The final set 
of mutations used to investigate the E185-R241 salt bridge utilized a swap mutation, E185R-
R241E. This produced a non-functional receptor which was likely caused by removal of 
critically important E185 which likely also interacts with GABA, as indicated by others 
(Bergmann et al., 2013; Newell et al., 2004).  
As previously described, E183 may form a salt bridge with K181 and possibly R241 
(Venkatachalan et al., 2008). However, the model of Hco-UNC-49 showed a distance too great 
between R241 and E183 to form a salt bridge, and thus only an interaction between E183 and 
K181 was investigated.  Mutations of E183A showed a decreased sensitivity to GABA of ~19 
fold relative to wild-type. This indicates that E183 is indeed important for receptor function. 
However, in order to further characterize the association of these residues, further analysis will 
be required. 
Two other potential salt bridges were investigated. This included D83-H137 and D83-R159, 
as D83 is within reasonable proximity to form a salt bridge with both of these residues (3.560Å 
and 3.436Å, respectively). It has been shown that this histidine (H107 in GABAA) regulates the 
Zn2+ inhibition in GABAA receptors (Dunne et al., 2002). Mutations of H107A demonstrated 
non-functional channels in GABAA (Dunne et al., 2002). Furthermore, mutations to either lysine 
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or arginine, both of which maintain the positive charge of histidine, showed non-responsive 
channels (Dunne et al., 2002).  It has been suggested that H107 may not be important for 
assembly, folding or transport of the GABAA receptor, but may be important for ion channel 
gating (Dunne et al., 2002). Crystal structures of the GABAA channel show that H107 does in 
fact participate in ion selection and the flow of chloride ions (Miller et al., 2014). This is 
accomplished through interactions with other amino groups in positions 104 and 105 (Miller et 
al., 2014). Based on the literature for the GABAA receptor, it could be concluded that H137 of 
Hco-UNC-49B does not participate in a salt bridge with D83. However, our electrophysiological 
results varied from the results demonstrated by Dunne at al., (2002). When the H. contortus 
H137A mutation was analyzed it was found to have an EC50 of 2174μM for GABA, an 
approximately 34 fold decrease in sensitivity relative to wild-type. While this is a disruption in 
function for the channel, it still demonstrates a somewhat functional channel.  The mutation 
H137K demonstrated an EC50 of 4166μM, an approximately 65 fold decrease in sensitivity. This 
shows that despite the conservation of charge the receptor is still impaired.  
The final mutation to test the potential salt bridge required a swap mutation of D83H-H137D. 
It was found that this mutant had an EC50 of 1315uM. While this does demonstrate some rescue 
of function for the channel, it is still far from the wild type responses which suggests that this is 
not a salt bridge. However, further analysis would be required to determine if D83 and H137 are 
energetically linked. 
 D83 appears to be essential for receptor function as a mutation to an alanine produced a non-
functional channel. Interestingly, a mutation which conserved the charge, D83E, showed a 
drastically improved EC50 of 276.1uM. However, the GABAA crystal structure showed the β3 
homomeric channel to be functional despite the fact that an equivalent D83 is not present (the 
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analogous residue is T62) (Miller et al., 2014). In order to test whether or not a charged residue 
is required at this position in Hco-UNC-49B, D83T was analyzed. It was found that while it is 
not as sensitive as D83E, there is still a drastic improvement of function relative to the D83A 
mutant, with an EC50 of 519.7uM. It should also be noted that while the GABAA β3 homomeric 
channel is functional and lacks D83, the wild type channel is thought to be composed of a 
heteromeric channel including an α1 subunit which contains an aspartic acid at the equivalent 
position. With these results, there appears to be a unique nature to the D83 residue that has not 
previously been described in H. contortus or even human GABA receptors. 
The research described here as well as research into other GABA receptors is consistent with 
the notion that there is some type of interaction between D83 and R159. For example, molecular 
simulations of the related invertebrate GABA receptor RDL has revealed a salt-bridge between 
D83 and R159. In the RDL, the analogous residue to R159 (which is R178) is located at the 
bottom of loop E where it forms an ionic interaction with D107, the equivalent to D83 in H. 
contortus (Ashby et al., 2012). In the present study when an R159A mutation was introduced the 
EC50 increased to 5469uM. Likewise, R159K showed no response at concentrations less than 
20mM. The final mutation generated to test the presence of a salt bridge was the D83-R159 
swap. This mutation drastically rescued the function of the channel with an EC50 of 598.5uM, 
albeit not as much as D83E. However, our model also suggests that R159 may also interact with 
E131 (Figure 18). Therefore, the swap mutation may disrupt this additional E131-R159 salt 
bridge, whereas the D83E mutation does not. It is still interesting though that D83T is relatively 
functional which suggests that the lack of charge at position 83 is tolerated. Again, further 
analysis is required to determine if D83 and R159 are energetically linked and the nature of this 
potential interaction. However, one experiment that points to a charge role of R159 is the 
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experiment using MTSET on a R159C mutant. When subjected to the compound MTSET, 
R159C shows an increased response to GABA. It has been suggested that an increased response 
with MTSET may be due to indirect effects of modifications and may alter gating or affinity for 
GABA (Boileau et al., 1999). It has also been suggested that MTSET may be utilized to predict 
the presence of salt bridges, as it has a positive charge (Venkatachalan et al., 2008). Experiments 
demonstrating an interaction between E153C and K196C of the human GABAA receptor found 
that the use of MTSES and MTSET increased current amplitude in response to GABA 
(Venkatachalan et al., 2008). This supports the prediction that R159 may be interacting with 
either D83 or E131 as a salt bridge.  While this is not conclusive evidence of a salt bridge, it does 
demonstrate the importance of these residues. Further research will be needed to determine the 
interaction that is occurring. Table 3 summarizes what is known about the interactions between 
residues in the human GABAA receptor 
Table 3. Summary of the comparison of residues between Hco-UNC-49B and the Human GABAA receptors 
including the specific interactions found in GABAA 
Hco-UNC-49B Human GABAA Specific Interaction 
in GABAA 
Reference 
D83 α1D62, β3T62  Not determined Boileau et al., 1999; 
Miller et al., 2014 
H137 β3H107 Found to participate 
in ion selectivity 
Miller et al., 2014 
R159 β3R131 Salt bridges between 
β3R131-β3D101  
Miller et al., 2014 
E131 β3D101 













9. Impact and conclusion 
  The objective of this thesis was to further characterize Hco-UNC-49B, the GABA 
receptor of H. contortus. This was accomplished by investigating four potential salt bridges 
found in conserved regions of Hco-UNC-49B.  The amino acids which were thought to 
contribute to these salt bridges were analyzed through a series of mutations. The first set of 
mutations were designed to remove each half of the salt bridge, one at a time. The second set of 
mutations were designed to rescue function by utilizing a charged amino acid which differed 
from the wild type sequence. Finally, the last set of mutations were designed to restore the salt 
bridge by swapping the two residues. It was found that mutations of E185 consistently resulted in 
nonfunctional channels, which has been found previously in both RDL and GABAA channels, 
both of which suggest a bridge from E185-R241. The electrophysiological results, accompanied 
by the model generated, are supported by the literature and suggest that this bridge is present in 
Hco-UNC-49B as well. A salt bridge may be present between R241-E183 based on literature. 
However, our model suggests that E183-K181 is too far away for this to occur. Further 
experimentation will be required to determine if there is a novel salt bridge at this location. 
Finally, two salt bridges were proposed to be participating with D83. This included D83-H137 
and D83-R159. Based on the research on H137 in other GABA receptors it is thought to play a 
role in ion selection and does not participate in a salt bridge. The electrophysiological results 
suggest that D83 may be participating in an interaction with R159. While our model 
demonstrates a potential interaction the nature of this interaction requires further study. 
However, it is clear that both residues (D83 and R159) are critical for receptor function.  
 The Hco-UNC-49B/C receptor is unique and functions differently from other RDL like 
receptors and vertebrate GABAA receptors. Because of this, Hco-UNC-49B/C shows promise as 
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a new target for anthelmintic drugs.  Not only does Hco-UNC-49B/C demonstrate a unique 
pharmacological profile compared to other known GABA receptors (Kaji et al., 2015), it may 
also have unique structural differences that explain functional differences. Characterization of 
the channel through intramolecular and intermolecular interactions may help in uncovering the 
structural and functional differences of Hco-UNC-49B/C and elicit how they may be used as a 
drug target. While this thesis revealed the interactions between some of the conserved charged 
residues of Hco-UNC-49B, there are still many to be investigated. The knowledge found in this 
investigation of the structure of Hco-UNC-49B will widen the understanding of a unique class of 
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 The following appendix highlights the primers used in this study and additional 
experimentation and results achieved during my studies at UOIT. 
 
  
11.1. Primers for the mutants generated for intramolecular analysis 
Table 1.  Hco-UNC49B charged residue mutagenesis Primers. Each mutagenesis primer name indicates the residue 
to be mutated, the position in the sequence, and the new residue in the mutant. Primers were designed using 
Stratagene’s web-based QuikChange® Primer Design Program. 
Mutagenesis 
Primer Name 
Forward Primer (sense) Reverse primer (antisense) 













































































































































11.2. Characterization of Loop E residues utilizing the Substituted Cysteine 
Accessibility Method 
Previously, Substituted Cysteine Accessibility method (SCAM) was performed on the first 
half of Loop E and demonstrated a number of important residues. In order to fully understand 
this loop’s participation with GABA, the residues D151, G152, T153, V154, and R159 were 
analyzed. Of the five mutants tested and modified by MTSET, only two, T153C and R159C 
effected GABA activation (caused an increased response). It is interesting to note that both of 
these residues are predicted to line the binding site of GABAA utilizing SCAM (Bergmann et al., 
2013). T153C showed a 143% ± 9.85 response after MTSET relative to its response to GABA, 




Figure 1. A: Representative responses before and after MTSET for R159C and T153C at their respective 





11.3. Characterization of Hco-UNC-49 utilizing GABA Analogues 
In order to further characterize the wild-type Hco-UNC-49 B/C receptor, a number of 
compounds were developed (Forrester and Desaulniers, unpublished data). These compounds 
were composed of six GABA analogues (Appendices Table 2), and analyzed through 
electrophysiological studies as previously described. Of the six analogues created, only two 
demonstrated the ability to activate the receptor. These two molecules, (E)-3-carboxyprop-2-en-
1-aminium (TACA), and 4-(hydroxyamino)-4-oxobutan-1-aminium showed comparable 
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responses to activation by GABA. In order to further analyze these analogues, EC50 were 
calculated using electrophysiology. 
Table 2. GABA analogues to be used on the WT (wild-type) UNC-49 channel of H. contortus.  















Table 3. EC50 calculations of the two GABA analogues known as Molecule B (TACA) and Molecule D (4-
(hydroxyamino)-4-oxobutan-1-aminium) are compared to the heteromeric UNC-49B/C receptor with GABA. 
Compound EC50 ± S.E. (μM) Number of oocytes 
Wild-Type 68.03±17.3 6 
Molecule B (TACA) 290.4 ± 15.05 9 
Molecule D 194.3 ± 8.239 8 
 
Figure 2. Dose response curves for the two GABA analogues, Molecule B (TACA) and Molecule D (4-
(hydroxyamino)-4-oxobutan-1-aminium). 
 
11.4. Pharmacological study of D83T 
Due to the fact that D83 showed such interesting results with the knock out D83A mutation 
and because a functional GABAA β3 homomeric receptor maintains activity while lacking D83, 
it was decided to that the potential function of this residue would be investigated. In order to 
achieve this, three other agonists were analyzed: IMA, R-GABOB and S-GABOB, as well as one 
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inhibitor, gabazine. These agonists were used to determine if they could elicit a full agonistic 
response in the D83T receptor by comparing each compound at 10mM, as indicated in 
Appendices Figure 3. IMA acted as a full agonist with responses on average being higher than 
that of GABA, at 110% relative to maximal GABA concentrations. R-GABOB nearly functioned 
as a full agonist with an average 78.5% response. Finally S-GABOB demonstrated only partial 
agonistic effect showing only 54% that of a maximal GABA response. The antagonist gabazine 




Figure 3. A: Representative responses of D83T with GABA, IMA, R-GABOB and S-GABOB at 10mM. EC50 
responses for D83T shown with Gabazine underneath. B: Pharmacological results of D83T comparing the responses 
of each compound relative to GABA. C: Chemical structures of GABA, S-GABOB, R-GABOB and IMA 
 
